Showing results (101-110 of 116) with videos related to
Sort By:
Pageof 12
JACC. Advances|November 21, 2025
Characteristics and Prognosis of Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Diagnosed Before 65 Years OldDamien Guijarro, Jean-Christophe Eicher, Mélanie Bézard, et al.JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.Circulation. Cardiovascular Interventions|October 18, 2022
Predictors of Clinical Success After Transcatheter Paravalvular Leak Closure: An International Prospective Multicenter RegistrySébastien Hascoët, Grzegorz Smolka, David Blanchard, et al.Archives of Cardiovascular Diseases|June 26, 2018
Multimodality imaging guidance for percutaneous paravalvular leak closure: Insights from the multi-centre FFPP registerSébastien Hascoet, Grzegorz Smolka, Francois Bagate, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 19, 2026
Medium-term outcomes and prognostic factors after transcatheter paravalvular leak closure: an international prospective multicentre registryGrégoire Albenque, Grzegorz Smolka, David Blanchard, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|February 7, 2023
Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathyFarah Cadour, Morgane Quemeneur, Loic Biere, et al.International Journal of Cardiology|June 18, 2025
Impact of Tafamidis on survival in elderly patients: Insights from the Healthcare European Amyloidosis RegistryAntoine Jobbé-Duval, Mounira Kharoubi, Erwan Donal, et al.Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.Pageof 12